Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byAbbott Labs
Price$400M
Date7/2013

General Information

Offices

Corporate Headquarters
3100 Coronado Drive
Santa Clara, CA, 95054
USA

People

Chief Financial Officer
President , Chief Executive Officer & Board of Directors
Vice President Global Marketing and International Sales
Vice President of Operations
Vice President, Regulatory, Clinical and Quality
Vice President of Clinical Sciences and Global Advocacy
Vice President of Research and Development
Vice President of Sales
Show All People

Funding

TOTAL $81.2M
FUNDING TOTAL $81.2M
Series C, 3/2008
Kleiner Perkins Caufield & Byers
Alloy Ventures
DAG Ventures
$16M
Partial Close, 8/2009
$30.2M
Series E, 5/2013
Kleiner Perkins Caufield & Byers
Alloy Ventures
DAG Ventures
BlackRock
$35M

Tags

OptiMedica

OptiMedica Corporation is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. The company was founded in 2004 with the vision of bringing innovative new technologies to ophthalmologists and transforming existing standards of care.

Since its founding, OptiMedica has been developing a reproducible, noninvasive technique to replace the inconsistent manual steps in cataract surgery with femtosecond laser technology. The system has been designed to deliver new levels of precision, control, performance, and efficacy to cataract surgeons and their patients. OptiMedica has completed clinical trials of its Catalysâ„¢ Precision Laser System, with very promising results reported across these measures. While the Catalys Precision Laser System is not currently for sale in the United States, OptiMedica expects to launch the system in U.S. and international markets in 2011.

Recent Milestones

Videos

Screenshots

OptiMedica screenshot
Above: OptiMedica
Uploaded: 7/10/09

Products

Catalys Precision Laser System

Add some content to this product

Sources

  1. Abbott to pay up to $400M to buy OptiMedica (bizjournals.com) [edit]
  2. OptiMedica Secures $16 Million in Series C Funding (optimedica.com) [edit]
  3. SEC (sec.gov) [edit]
  4. OptiMedica, Corp.: Series E $35M (onbiovc.com) [edit]
Edit This Page
Last Edited 2/25/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy